Anticancer effect obtained against MCA205 sarcoma following treatment with the oncolytic peptide LTX-315 in combination with immune checkpoint inhibitors. (4th November 2015) - Rekdal, Öystein; Yamazaki, Takahiro; Sveinbjornsson, Baldur; Saunders, Andrew; Zitvogel, Laurence